Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis.
Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease.
Vitamin D supplementation and antibodies against the Epstein-Barr virus in multiple sclerosis patients.
Timed 25-Foot Walk: Direct evidence that improving 20% or greater is clinically meaningful in MS.
Explaining, not just predicting, drives interest in personal genomics.
G protein-coupled receptor kinase 2 and group I metabotropic glutamate receptors mediate inflammation-induced sensitization to excitotoxic neurodegeneration.
[The effect of tobacco smoking on clinical effectiveness of immunomodulatory treatment in multiple sclerosis patients].
Sarcoidosis associated with neuromyelitis optica.
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants.
Assessing risks of multiple sclerosis therapies.
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions.
A pilot study of a telehealth intervention for persons with spinal cord dysfunction.
Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells.
Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory.
Variations in predicted risks in personal genome testing for common complex diseases.
Circulating CCR7+ICOS+ Memory T Follicular Helper Cells in Patients with Multiple Sclerosis.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Fingolimod therapy for multiple sclerosis.
Dynamic Assessment of Social Cognition in Individuals with Multiple Sclerosis: A Pilot Study.
Immunoadsorption in steroid-refractory multiple sclerosis: Clinical experience in 60 patients.
The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia.
Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation.
Dendritic cells in multiple sclerosis: key players in the immunopathogenesis, key players for new cellular immunotherapies?
Management of Multiple Sclerosis in the Breastfeeding Mother.
Brain glycolipids suppress T helper cells and inhibit autoimmune demyelination.

Pages